Br J Hosp Med (Lond). 2009 May;70(5):298-9. doi: 10.12968/hmed.2009.70.5.42238.
PMID:19451879
Post COVID-19 rhinocerebral mucormycosis: a case report and literature review.
El Korbi A, Bhar S, Bergaoui E, Harrathi K, Koubaa J.
Pan Afr Med J. 2022 Jul 14;42:202. doi: 10.11604/pamj.2022.42.202.33690. eCollection 2022.
PMID:36284570
Rhinocerebral mucormycosis in immunocompetent patients: a case report and review of literature.
Ajdari A, Zolfagharypoor A, Firouzifar M, Akbarpour M.
Infection. 2024 Apr;52(2):673-684. doi: 10.1007/s15010-023-02147-z. Epub 2023 Dec 28.
PMID:38153685
Rhinocerebral mucormycosis: an update.
Mallis A, Mastronikolis SN, Naxakis SS, Papadas AT.
Eur Rev Med Pharmacol Sci. 2010 Nov;14(11):987-92.
PMID:21284348
COVID-associated rhinocerebral mucormycosis: a retrospective analysis of presentation and outcomes.
Moorthy A, Nayak T, Bachalli PS, Tripathi KK, Dutt SN, Kale P, Bhat P, Suresh PK, Gaikwad R, Raju A, Krishna S, Conjeevaram A, Mehta S, Anil-Kumar A, Haldipur D.